SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-4.9%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.47B
AUM Growth
+$2.47B
(-8.5%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
112
New
16
Increased
28
Reduced
14
Closed
11
Top Buys
| 1 |
Home Depot
HD
|
$35.8M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$31.6M |
| 3 |
Bank of America
BAC
|
$31.5M |
| 4 |
89bio
ETNB
|
$30M |
| 5 |
Chipotle Mexican Grill
CMG
|
$27.1M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$97.4M |
| 2 |
Coca-Cola
KO
|
$51.7M |
| 3 |
Starbucks
SBUX
|
$47M |
| 4 |
CRH
CRH
|
$37.2M |
| 5 |
McDonald's
MCD
|
$30M |
Sector Composition
| 1 | Healthcare | 65.45% |
| 2 | Technology | 11.42% |
| 3 | Consumer Discretionary | 7.21% |
| 4 | Financials | 5.81% |
| 5 | Communication Services | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Medtronic
MDT
$119B
| $2.25M | 0.08% | 25,060 +7,600 | +44% | +$683K |
|
77
Stryker
SYK
$150B
| $2.18M | 0.08% | 5,860 +1,500 | +34% | +$558K |
|
78
DexCom
DXCM
$29.5B
| $2.16M | 0.08% | 31,680 | – | – |
|
79
Trevi Therapeutics
TRVI
$883M
| $2.14M | 0.08% | +340,164 | New | +$2.14M |
|
80
Natera
NTRA
$23.1B
| $1.43M | 0.05% | 10,100 | – | – |
|
81
Oric Pharmaceuticals
ORIC
$994M
| $1.42M | 0.05% | +255,000 | New | +$1.42M |
|
82
IQVIA
IQV
$32.4B
| $1.26M | 0.05% | 7,175 | – | – |
|
|
83
CRH
CRH
$75.9B
| $1.24M | 0.05% | 14,050 -422,344 | -97% | -$37.2M |
|
84
McKesson
MCK
$85.4B
| $1.23M | 0.05% | 1,830 | – | – |
|
85
Elevance Health
ELV
$71.8B
| $1.19M | 0.04% | 2,740 | – | – |
|
86
Avantor
AVTR
$9.18B
| $1.16M | 0.04% | 71,850 | – | – |
|
87
Waters Corp
WAT
$18B
| $1.16M | 0.04% | 3,150 | – | – |
|
88
Sarepta Therapeutics
SRPT
$1.78B
| $1.14M | 0.04% | 17,888 | – | – |
|
89
HCA Healthcare
HCA
$94.5B
| $1.1M | 0.04% | 3,190 | – | – |
|
90
Galapagos
GLPG
$2.07B
| $932K | 0.03% | 37,111 | – | – |
|
91
Edwards Lifesciences
EW
$47.8B
| $805K | 0.03% | 11,100 | – | – |
|
92
Agilent Technologies
A
$35.7B
| $584K | 0.02% | 4,990 | – | – |
|
93
ResMed
RMD
$40.2B
| $535K | 0.02% | 2,390 | – | – |
|
94
Veralto
VLTO
$26.4B
| $534K | 0.02% | 5,475 | – | – |
|
95
Zimmer Biomet
ZBH
$21B
| $369K | 0.01% | 3,260 | – | – |
|
96
Steris
STE
$24.1B
| $347K | 0.01% | 1,530 | – | – |
|
97
Ionis Pharmaceuticals
IONS
$6.79B
| $326K | 0.01% | 10,800 | – | – |
|
98
Baxter International
BAX
$12.7B
| $273K | 0.01% | 7,970 | – | – |
|
99
PACS Group
PACS
$1.81B
| $225K | 0.01% | 20,000 | – | – |
|
100
Align Technology
ALGN
$10.3B
| – | – | -1,100 | Closed | -$229K |
|